Status:
COMPLETED
Comparison of Two FiO2 (1 or 0.5) for Tracheal Extubation in Post-anesthesia Care Unit
Lead Sponsor:
University Hospital, Caen
Conditions:
Anesthesia
Atelectasis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of the study is to assess the optimal fraction of inspired oxygen (0.5 or 1) for extubation or removal of a supraglottic airway device after general anesthesia.
Detailed Description
During pre-anesthesia visit, eligible patients receive oral and written information of the study and potential risks. In the operating room all patients giving a written informed consent will undergo...
Eligibility Criteria
Inclusion
- Patients undergoing general anesthesia, with invasive mechanical ventilation including an airway device (supraglottic airway device or tracheal tube) at their arrival in PACU.
- ASA physical status classification 1, 2, or 3 stabilized.
- Surgery performed in emergency operating room department including vascular, digestive, urological and minor trauma surgery or surgery performed in head and neck anesthesia pole block including anterior cervical spine, lumbar disc herniation, cranioplasty, nerve stimulator, vertebroplasty, narrow lumbar canal, simple arthrodesis (less than or equal to two stages), otological, ophthalmological and skin surgery.
Exclusion
- Per-operative hemodynamic instability.
- Patients with a BMI greater than 35.
- Patients classified as difficult to intubate and / or ventilate.
- Heavy surgeries (operating time greater than 4 hours).
- Patient requiring postoperative non invasive mechanical ventilation
- Patients with diagnosed COPD
- SPO2 in room air \< 96% before the intervention.
- Any patient under guardianship.
- Pre-operative and / or intra-operative morphine intake.
- Surgical management of the upper airways (ex : tonsillectomy)
- Pregnant and lactating women.
Key Trial Info
Start Date :
April 9 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 16 2021
Estimated Enrollment :
119 Patients enrolled
Trial Details
Trial ID
NCT04879290
Start Date
April 9 2021
End Date
August 16 2021
Last Update
November 3 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital, Caen
Caen, France, 14033